For Investors
Every drug that reaches a human was first tested in a rodent — and the critical readout is still scored by hand. Virtual Labs is building the instruments, the platform, and ultimately the virtual animals that change that. Permanently.
The Opportunity
Behavioral endpoints inform billion-dollar clinical decisions — yet most are still scored by a human with a stopwatch, on hardware that hasn't fundamentally changed in decades. Rodent research is one of the largest unmodernized workflows in life science.
The Thesis
Virtual Labs is not another camera company. It's a data strategy executed through instruments researchers actually want — and the dataset it compounds is what makes predictive behavioral SAR possible: relating a molecule's structure not just to a target, but to the behavior of the whole animal.
Our instruments capture behavioral signal at a fidelity legacy systems structurally cannot — protected by patent-pending optics and priced to deploy widely.
MouseOS carries no license fee and analyzes video from any camera — including installed hardware from other vendors. Every analyzed session deepens one standardized dataset.
The FDA Modernization Act 2.0 and the agencies' New Approach Methodologies roadmaps all point toward documented animal reduction. Virtual Control Groups are the answer labs are searching for.
Standardized, high-fidelity behavioral data at scale is the training corpus for generative models of animal behavior — virtual subjects that reduce, and increasingly replace, live experiments.
Founder-Led, Domain-Deep
Virtual Labs was founded by a Harvard-trained neuroscientist and serial biotech founder whose research and companies have defined the frontier of behavioral measurement — from a landmark Nature Neuroscience discovery to multiple co-founded CNS companies with $70M+ raised across them. The optics, the assays, and the market are home turf.
Virtual Labs has closed our first funding round — a pre-seed backed by veteran private-equity professionals investing personally — with follow-on interest already queued.
Get Involved
We selectively share detailed materials with qualified investors. If our thesis resonates, we'd like to hear from you.